SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-018144
Filing Date
2017-07-10
Accepted
2017-07-10 16:38:29
Documents
2
Period of Report
2017-07-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1558
2 EX-24 DOCUMENT attachment1.htm EX-24 4000
  Complete submission text file 0000899243-17-018144.txt   6964
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Dere Willard H (Reporting) CIK: 0001311569 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 17958164

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations